Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs

Emerging Infectious Diseases

Volumn 18, Issue 1, 2012, Pages 13-20

  Jackson, Michael L ^a,b   Rose, Charles E ^a   Cohn, Amanda ^a   Coronado, Fatima ^a   Clark, Thomas A ^a   Wenger, Jay D ^a   Bulkow, Lisa ^a   Bruce, Michael G ^a   Messonnier, Nancy E ^a   Hennessy, Thomas W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; DISEASE TRANSMISSION; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE TYPE B DISEASE; HERD IMMUNITY; INCIDENCE; INDIGENOUS PEOPLE; POPULATION RESEARCH; PREVENTIVE MEDICINE; SIMULATION; UNITED KINGDOM; UNITED STATES;

CHILD; CHILD, PRESCHOOL; ENGLAND; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNITY, HERD; INCIDENCE; INDIANS, NORTH AMERICAN; INFANT; MODELS, BIOLOGICAL; TIME FACTORS; UNITED STATES; WALES;

EID: 84856560324     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1801.110336     Document Type: Article

References (30)

1. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-6.
2. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet. 2005;366:144-50. doi:10.1016/S0140-6736(05)66788-8
3. Ramsay ME, McVernon J, Andrews NJ, Heath PT, Slack MP. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis. 2003;188:481-5. doi:10.1086/376997
4. Singleton R, Hammitt L, Hennessy T, Bulkow L, DeByle C, Parkinson A, et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics. 2006;118:e421-9. doi:10.1542/peds.2006-0287
5. McVernon J, Howard AJ, Slack MPE, Ramsay ME. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect. 2004;132:765-7. doi:10.1017/S0950268804002122
6. Mohle-Boetani JC, Ajello G, Breneman E, Deaver KA, Harvey C, Plikaytis BD, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J. 1993;12:589-93. doi:10.1097/00006454-199307000-00009
7. Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis. 1999;179:101-6. doi:10.1086/314569
8. Oh SY, Griffiths D, John T, Lee YC, Yu LM, McCarthy N, et al. School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. J Infect Dis. 2008;197:1275-81. doi:10.1086/586716
9. Centers for Disease Control and Prevention. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). MMWR Morb Mortal Wkly Rep. 2007;56:1318-20.
10. Centers for Disease Control and Prevention. Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine. MMWR Morb Mortal Wkly Rep. 2009;58:1008-9.
11. Bruce M, Singleton R, Lem M, Zulz T, Wenger J, Hennessy T. Haemophilus disease in Alaskan and Canadian children [author reply]. Pediatr Infect Dis J. 2010;29:186-7. doi:10.1097/INF.0b013e3181c37e03
12. Hampton CM, Barenkamp SJ, Granoff DM. Comparison of outer membrane protein subtypes of Haemophilus influenzae type b isolates from healthy children in the general population and from diseased patients. J Clin Microbiol. 1983;18:596-600.
13. Michaels RH, Poziviak CS, Stonebraker FE, Norden CW. Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children. J Clin Microbiol. 1976;4:413-7.
14. Stillman EG. Occurrence of H. influenzae in throats of adults. Yale J Biol Med. 1945;18:37-40.
15. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996;45:901-6.
16. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51:234-7.
17. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network Haemophilus influenzae, 2001. 2002 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib01.pdf
18. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network, Haemophilus influenzae 2002. 2003 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib02.pdf
19. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network, Haemophilus influenzae 2003. 2004 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib03.pdf
20. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network, Haemophilus influenzae 2004. 2005 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib04.pdf
21. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network, Haemophilus influenzae 2005. 2006 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib05.pdf
22. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network, Haemophilus influenzae 2006. 2007 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib06.pdf
23. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report Emerging Infections Program Network, Haemophilus influenzae 2007. 2008 [cited 2009 Nov 15]. http://www.cdc.gov/abcs/reports-findings/survreports/hib07.pdf
24. Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr. 1992;121:187-94. doi:10.1016/S0022-3476(05)81186-2
25. White KE, Pabst LJ, Cullen KA. Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage. Pediatrics. 2011;127:e707-12. doi:10.1542/peds.2010-2129
26. Coen PG, Heath PT, Garnett GP. The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease. Epidemiol Infect. 1999;123:389-402. doi:10.1017/S0950268899002952
27. Leino T, Takala T, Auranen K, Makela PH, Takala AK. Indirect protection obtained by Haemophilus influenzae type b vaccination: analysis in a structured population model. Epidemiol Infect. 2004;132:959-66. doi:10.1017/S095026880400250X
28. McVernon J, Ramsay ME, McLean AR. Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom. Epidemiol Infect. 2008;136:800-12. doi:10.1017/S0950268807009168
29. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.). Wkly Epidemiol Rec. 2006;81:445-52.
30. World Health Organization. WHO vaccine preventable diseases monitoring system. 2010 [cited 2010 Jun 18]. http://apps.who.int/immunization_monitoring/en/globalsummary/scheduleselect.cfm